Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
Case Rep Oncol ; 9(1): 273-9, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27462227

RESUMO

Primary effusion lymphoma (PEL) is a rare condition, which accounts for approximately 4% of all human immunodeficiency virus (HIV)-associated non-Hodgkin lymphomas. PEL has a predilection for body cavities and occurs in the pleural space, pericardium, and peritoneum. Without treatment, the median survival is approximately 2-3 months, and with chemotherapy, the median survival is approximately 6 months. We describe the case of a 47-year-old male with HIV and Kaposi's sarcoma who presented with complaints of abdominal pain and distension and was subsequently diagnosed with PEL. Despite limited clinical data being available, chemotherapy with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) has proven to increase survival rates in patients with this condition.

4.
Radiat Oncol ; 7: 140, 2012 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-22908888

RESUMO

Radiotherapy for prophylaxis of heterotopic ossification (HO) is commonly used in high risk patients following orthopedic surgery. While treatment is effective and can prevent morbidity associated with HO, with any dose of radiation there is a concern of a radiation induced malignancy. Here we a report a case of radiation induced osteosarcoma which developed 11 years after a single fraction of 700 cGy. We performed dosimetric analysis by superimposing the patient's original treatment field on a CT scan performed after the diagnosis. The radiotherapy dose for this patient is lower than classically reported for radiation induced sarcomas. We identified greatest bony destruction that was thought to be the epicenter of the tumor, and this was specially contoured on the diagnostic CT scan. This volume appears to be located at the edge of the radiotherapy field. Fifty percent of the treated volume received 240 cGy, the mean dose was 333 cGy. There was a variation across the treatment volume, between 21.8 cGy and 717 cGy. While a rare complication, we stress the importance of informing regarding the risk of a radiation induced malignancy following HO prophylaxis.


Assuntos
Neoplasias Ósseas/etiologia , Ossificação Heterotópica/radioterapia , Osteossarcoma/etiologia , Lesões por Radiação/etiologia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Ósseas/tratamento farmacológico , Cisplatino/administração & dosagem , Doxorrubicina/administração & dosagem , Humanos , Masculino , Estadiamento de Neoplasias , Ossificação Heterotópica/complicações , Osteossarcoma/tratamento farmacológico , Prognóstico , Lesões por Radiação/tratamento farmacológico
5.
J Cancer Res Ther ; 8(1): 138-41, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22531535

RESUMO

The traditionally held view is that the patients with metastatic disease cannot be cured and should be treated palliatively as it was believed that the patients will eventually succumb to the disease progression due to lack of effective treatments for systemic disease. In this article, we report our experience in a patient who was diagnosed with metastatic oropharynx squamous cell carcinoma to the liver, who has now survived five years since the original diagnosis, and is three years disease free. This case report illustrates the curative potential in selected patients with limited burden of metastatic disease with aggressive local therapy to all known sites of disease. It underscores the importance of imaging modalities in monitoring progression of disease, and most importantly illustrates the importance of multidisciplinary care for oncology patients.


Assuntos
Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/secundário , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/secundário , Neoplasias Orofaríngeas/patologia , Carcinoma de Células Escamosas/patologia , Quimiorradioterapia , Terapia Combinada , Seguimentos , Humanos , Neoplasias Hepáticas/terapia , Masculino , Pessoa de Meia-Idade , Neoplasias Orofaríngeas/diagnóstico , Radiocirurgia , Resultado do Tratamento
7.
J Clin Densitom ; 5(3): 267-71, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12357064

RESUMO

Bone marrow transplantation is now an established successful treatment for several hematologic malignancies. Bone loss is among the long-term adverse effects of this procedure. The underlying pathophysiology is believed to be multifactorial. We report a case of osteoporosis in a young patient who underwent allogenic bone marrow transplantation for acute lymphoblastic leukemia that was complicated by intestinal graft-versus- host disease. Her bone density measurement showed T-scores of -3.46 and -2.47 in the lumbar spine and femoral neck respectively. On evaluation, she had low normal serum calcium, low urine calcium, low 25- hydroxyvitamin D, elevated total and bone specific alkaline phosphatases, and elevated parathyroid hormone. Following treatment with calcifediol, the biochemical markers normalized and the bone mineral density increased by 88% in the lumbar spine and almost 60% in the femoral neck, both of which were above the mean for her age group. We believe that the graft-versus-host disease caused a malabsorptive state that led to vitamin D deficiency and possible resistance and consequent osteomalacia.


Assuntos
Densidade Óssea/efeitos dos fármacos , Transplante de Medula Óssea/efeitos adversos , Calcifediol/uso terapêutico , Osteomalacia/tratamento farmacológico , Adolescente , Transplante de Medula Óssea/fisiologia , Feminino , Doença Enxerto-Hospedeiro/complicações , Humanos , Osteomalacia/etiologia , Osteomalacia/fisiopatologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...